Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5850
-0.0150 (-2.50%)
Jul 17, 2026, 4:10 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 202.35 million as of July 17, 2026. Its market cap has increased by 2.00% in one year.
Market Cap
202.35M
Enterprise Value
185.07M
Revenue
86.47M
Ranking
n/a
PE Ratio
54.47
Stock Price
0.59
ChartMarket Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 202.35M, a decrease of -50.05%. That is a compound annual growth rate of -10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 202.35M | -20.75% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 677.03M |
| Imricor Medical Systems | 577.96M |
| EBR Systems | 267.38M |
| EMVision Medical Devices | 150.59M |
| Saluda Medical | 129.79M |
| SomnoMed | 100.78M |
| Lumos Diagnostics Holdings | 79.33M |
| Epiminder | 73.56M |